Jump to content

Yuting Zhang

Add links
From Wikipedia, the free encyclopedia

Yuting Zhang is a professor of health economics at the University of Melbourne, and an expert on economic evaluations of health policy and healthcare reforms. She is a journal editor, award recipient, and has written numerous articles in influential journals in her field.

Biography

[edit]

Professor Zhang obtained her PhD in health policy (economics concentration) at Harvard University in 2007 and MS in health policy & management, also from Harvard University. She received her BA from Renmin University of China.

Yuting Zhang is currently a professor of health economics at the Melbourne Institute: Applied Economic & Social Research within the Faculty of Business and Economics at the University of Melbourne. She is currently the founding director for the Health Analytics, Leadership, and Economics (HALE) Hub. Before that, she was a tenured professor at the University of Pittsburgh. She was the founding director of the Pharmaceutical Economics Research Group since 2010.

Her expertise is with using advanced econometrics and statistical methods and large data sets to design rigorous observational studies to study causal relationship between health policy/interventions and outcomes including patient health, healthcare spending, and quality of care. These empirical studies are motivated by two overarching goals: first, to design studies to identify causal relationships between health policy/interventions and health outcomes rather than mere correlations; second, to provide guidance on how health policies can be designed to achieve efficiency and high quality of care in the healthcare system.

Her research areas include pharmaceutical policy and economics, mental health policy, value-based healthcare design, comparative effectiveness analysis, health insurance markets, the effect of healthcare reforms on healthcare spending and quality of care, and international health.

Zhang's research has been published in prestigious medicine, health policy, and economics journals such as the New England Journal of Medicine,[1] Health Affairs,[2] and the American Economic Review.[3]

Zhang has been interviewed extensively by reporters from television or radio broadcast, magazines and newspapers, including The New York Times,[4] The Wall Street Journal,[5] American Health Line,[6] USA Today [7] Business Week,[8] The Washington Post,[9] ABC News [10] and CBS News [11]

She is on the advisory board of Lancet - Regional health west pacific, an associate editor of the Journal of Mental Health Policy and Economics, and an appointed method/statistical reviewer at JAMA Network Open. She has also served as a consulting advisor to the Institute of Medicine and the Centers for Medicare and Medicaid Services, and a reviewer for the NIH, Patient-Centered Outcomes Research Institute, and the US Medicare Payment Advisory Commission.

Major projects

[edit]

Zhang has led several large-scale projects with funding from the U.S. National Academies of Sciences, Engineering, and Medicine, the U.S. National Institutes of Health (NIH), Agency for Healthcare Research and Quality, and the Commonwealth Fund. Zhang is the recipient of an Australian Research Council Australian Future Fellowship award to study how to reform private health insurance in Australia.

Selected publications

[edit]

Zhang has published in hundreds of journals on the economics of public policy, including top economic and Health journals

  • Yuting Zhang, How can the Australian government make primary care and private health insurance more affordable? Australian Economic Review; online first: http://doi.org/10.1111/1467-8462.12553. 
  • Ou Yang, Jongsay Young, and Yuting Zhang, Effects of Private Health Insurance on Waiting Time in Public Hospitals. Health Economics. Online first 15 Feb 2024: https://doi.org/10.1002/hec.4811.
  • Zhang Y*, Newhouse JP, Baicker K. Are Drugs Substitutes or Complements for Intensive (and Expensive) Medical Treatment? American Economic Review. 2011 May; 101 (3):393-97. PMCID: 3778446.
  • Zhang Y*, Baik SH, Fendrick AM, Baicker K. Comparing local and regional variation in health care spending. The New England journal of medicine. 2012 Nov; 367 (18):1724-31. PMCID: PMC3490218. PMID 23113483.
  • Zhang Y*, Baicker K, Newhouse JP. Geographic variation in the quality of prescribing. The New England journal of medicine. 2010 Nov 18; 363 (21):1985-8. PMCID: PMC3047447. PMID 21047217
  • Zhang Y*, Baicker K, Newhouse JP. Geographic variation in Medicare drug spending. The New England journal of medicine. 2010 Jul 29; 363 (5):405-9. PMCID: PMC3364516. PMID 20538621
  • Zhang Y*, Donohue JM, Lave JR, O’Donnell G, Newhouse JP. The effect of Medicare Part D on drug and medical spending. The New England journal of medicine. 2009 Jul 2; 361 (1):52-61. PMCID: PMC2859614. PMID 19571283.
  • Liu L, Zhang Y*. Does non-employment based health insurance promote entrepreneurship? Evidence from a policy experiment in China. Journal of Comparative Economics. May 2017. https://doi.org/10.1016/j.jce.2017.04.003.
  • Zhang Y, Ma Q, Chen Y, Gao H. Effects of Public Hospital Reforms on Inpatient Expenditures in Rural China. Health Economics. 2016 Feb. doi: 10.1002/hec.3320 .
  • Kaplan CM, Zhang Y*. Anticipatory Behavior In Response To Medicare Part D's Coverage Gap. Health Economics. 2016 Jan. doi: 10.1002/hec.3311.
  • Kaplan CM, Zhang Y*. The January Effect: Medication Reinitiation among Medicare Part D Beneficiaries. Health Economics. 2014 Nov 14; 23 (11):1287-300. PMCID: 3841288 .
  • Kaplan C, Zhang Y*. Assessing the comparative-effectiveness of antidepressants commonly prescribed for depression in the US Medicare population. The journal of mental health policy and economics. 2012 Dec; 15 (4):171-8. PMCID: PMC3608926. PMID 23525835.
  • Baik SH, Rollman BL, Reynolds CF 3rd, Lave JR, Smith KJ, Zhang Y*. The effect of the US Medicare Part D coverage gaps on medication use among patients with depression and heart failure. The Journal of Mental Health Policy and Economics. 2012 Sep; 15 (3):105-18. PMCID: PMC3471664. PMID 23001279.
  • Zhang Y*. Cost-saving effects of olanzapine as long-term treatment for bipolar disorder. The journal of mental health policy and economics. 2008 Sep; 11 (3):135-46. PMID 18806303.
  • Huskamp HA, Frank RG, McGuigan K, Zhang Y. The Impact of A Three-Tier Formulary on Demand Response for Prescription Drugs. Journal of Economics and Management Strategy. 2005; 14 (3):729-753. PMID 18509214.
  • San-Juan-Rodriguez A, Zhang Y, He M, Hernandez I. Association of Antidementia Therapies with Time to Skilled Nursing Facility Admission and Cardiovascular Events among Elderly Adults with Alzheimer Disease. JAMA Network Open; March 2019;2(3):e190213. doi:10.1001/jamanetworkopen.2019.0213
  • Hernandez I, He M, Brooks M, Zhang Y. Exposure-Response Association between Concurrent Opioid and Benzodiazepine Use and Risk of Opioid-Related Overdose in Medicare Part D Beneficiaries. JAMA Network Open. June 2018;1(2):e180919. doi:10.1001/jamanetworkopen.2018.0919.
  • Zhang Y*, Baik SH, Zhou L, Reynolds CF, Lave JR. Effects of Medicare Part D coverage gap on medication and medical treatment among elderly beneficiaries with depression. JAMA Psychiatry (formerly Archives of General Psychiatry). 2012 Jul; 69 (7): 672-9. PMCID: PMC3390754. PMID 22752233.

Awards

[edit]

Professor Zhang has received multiple international awards including:

  • Australian Research Council Australian Future Fellowship award 2021-2025
  • Australian-American Health Policy Fellowship 2016-2017
  • Excellence in Mental Health Policy and Economics Research Award 2009
  • Hong Kong Hang Seng Bank Overseas Scholarship 1997 - 1999
  • Thomas O. Pyle Fellow, Harvard Medical School 2006-2007
  • Honors Convocations Award Recipient, University of Pittsburgh 2012, 2014, 2017
  • Dean's Certificate for Research Excellence, University of Melbourne

References

[edit]
  1. ^ Y Zhang, JM Donohue, JR Lave, G O'donnell… - "The effect of Medicare Part D on drug and medical spending" New England Journal of Medicine, 2009
  2. ^ Y Zhang, C Zhou, SH Baik - "A simple change to the Medicare Part D low-income subsidy program could save $5 billion" Health Affairs, 2014
  3. ^ Y Zhang, JP Newhouse, K Baicker - "Are drugs substitutes or complements for intensive (and Expensive) medical treatment" American Economic Review, 2011
  4. ^ Roni Caryn Rabin "Patterns: Medicare Coverage Drives Antibiotic Use" 17 August 2010 The New York Times
  5. ^ Katherine Hobson "Spending More on Drugs Doesn’t Mean Spending Less On Other Care" The Wall Street Journal Jun 10, 2010
  6. ^ "$4 Prescription Programs Could Save Consumers, Gov't $5.8B, Study Finds" American Health Line 17 March 2011
  7. ^ interviewed by Kim Painter, “Southeast paying health price for high antibiotic use”, USA Today, 11/13/2012
  8. ^ BusinessWeek, “With Medicare plan, drug spending may be up,” 07/01/2009, together with dozens of mentions in various online TV and newspapers
  9. ^ The Washington Post, “Will your doctor prescribe antibiotics? Depends on where you live”, 9/28/2012
  10. ^ Emily P Walker, ABC News "Antidepressants 'Fall' Through Doughnut Hole" medpage today washington correspondent July 5, 2012
  11. ^ “Elderly In South Use More Antibiotics Than Seniors In Other Areas Of Country”, CBS News, 9/26/2012
Retrieved from "https://en.wikipedia.org/w/index.php?title=Yuting_Zhang&oldid=1233488072"